Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
ITM Solucin GmbH
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
City of Hope Medical Center
Institut Curie
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Y-mAbs Therapeutics
Gradalis, Inc.
National Cancer Institute (NCI)
Eisai Inc.
Children's National Research Institute
Children's Oncology Group
City of Hope Medical Center
Eastern Cooperative Oncology Group
Istituto Ortopedico Rizzoli
Gradalis, Inc.
Institut Curie
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Assiut University
St. Jude Children's Research Hospital
Children's Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Children's Oncology Group
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Children's Oncology Group
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Children's Oncology Group